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Systematic discovery of genetic 
modulation by Jumonji histone 
demethylases in Drosophila
Nevine A. Shalaby1,4, Raheel Sayed1, Qiao Zhang1, Shane Scoggin1, Susan Eliazer1, Adrian 
Rothenfluh  2,3,5 & Michael Buszczak1
Jumonji (JmjC) domain proteins influence gene expression and chromatin organization by way 
of histone demethylation, which provides a means to regulate the activity of genes across the 
genome. JmjC proteins have been associated with many human diseases including various cancers, 
developmental and neurological disorders, however, the shared biology and possible common 
contribution to organismal development and tissue homeostasis of all JmjC proteins remains unclear. 
Here, we systematically tested the function of all 13 Drosophila JmjC genes. Generation of molecularly 
defined null mutants revealed that loss of 8 out of 13 JmjC genes modify position effect variegation 
(PEV) phenotypes, consistent with their ascribed role in regulating chromatin organization. However, 
most JmjC genes do not critically regulate development, as 10 members are viable and fertile with 
no obvious developmental defects. Rather, we find that different JmjC mutants specifically alter the 
phenotypic outcomes in various sensitized genetic backgrounds. Our data demonstrate that, rather 
than controlling essential gene expression programs, Drosophila JmjC proteins generally act to “fine-
tune” different biological processes.
The methylation of specific lysine residues on histone proteins has a direct impact on chromatin organization 
and gene expression programs1, 2. The catalytic Jumonji C (JmjC) domain defines a family of histone demeth-
ylases (KDMs) encoded by 30 genes in the human genome3, 4. Different JmjC proteins can positively or negatively 
influence transcription and are thought to serve as key regulators of gene expression in a broad number of con-
texts2, 5. Most of the JmjC genes have been associated with human diseases6. Mutations in JmjC genes that have 
been directly linked to human pathology include deletion of KDM3B in myeloid leukemias7 and breast cancer8, 
deletion of KDM5D in 50% of prostate cancers9, inactivatiing somatic mutations in KDM6A in multiple tumor 
types10, association of KDM7B mutations with autism spectrum disorders11, and disruption of normal circadian 
rhythms in JMJD5 mutants12. How different JmjC genes influence this spectrum of phenotypes and pathologies 
remains unclear.
Drosophila allows the systematic study of null mutant animals with exquisite control over genetic back-
grounds. The Drosophila genome encodes 13 JmjC genes compared to 30 human genes. These genes can be placed 
into seven JmjC subgroups based on shared protein domains with their human homologs4 (Fig. 1). This reduced 
redundancy greatly facilitates the functional characterization of this gene family. Lid and UTX represent the 
best-studied Drosophila JmjC proteins to date. A genetic screen initially identified lid as a trithorax- group gene 
and loss of lid strongly reduces viability2, 13. Subsequent efforts revealed that Lid demethylates H3K4me2/3 and 
interacts with the Drosophila Myc homolog to regulate cell growth14–16. Drosophila UTX targets H3K27me3 for 
demethylation, like its mammalian homolog17, 18. Loss of UTX results in lethality and defective HOX gene expres-
sion17, 19. Mutations in KDM4A and KDM4B interfere with transcriptional activation of the ecdysone receptor20 
and KDM4B heterozygotes are more sensitive to p53-dependent response to UV radiation21. While these exam-
ples focused on specific effects on single genes or pathways, a null mutant of KDM4A has also been shown to 
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mis-regulate 99 genes in larvae22. In contrast to these examples, the majority of Drosophila JmjC genes and their 
mutant phenotypes remain to be investigated.
Here, we generated strains bearing molecularly defined null mutations to systematically probe the shared and 
diverse functions of all 13 Drosophila JmjC genes. Complementary to recent mechanistic studies of specific target 
genes and pathways, we provide a comprehensive survey using quantitative genetic assays that take advantage of 
the strengths of the Drosophila system. Systematic null mutant analyses and redundancy tests reveal that only two 
of the 13 JmjC genes are lethal and one is semi-lethal, indicating that 10 of the 13 genes are not critically required 
for development. By contrast, several JmjC mutants affect different genetic backgrounds sensitized for various 
molecular pathways. These results indicate that modulation of JmjC gene function can influence gene expression 
programs in a variety of contexts.
Results
A complete set of 13 molecularly defined JmjC null mutants. To enable the systematic functional 
analysis of JmjC-domain proteins in Drosophila, we generated a knockout collection for all 13 annotated family 
members encoded in the genome (Fig. 1). Previous efforts identified mutations in lid, KDM4A, KDM4B, Jarid2, 
UTX and PSR13, 17, 19, 21–25. However, definitive loss-of-function mutations were not available for the other anno-
tated JmjC genes. To generate null alleles we used recombineering-based techniques to engineer donor constructs 
for ends-out homologous recombination26–28. These constructs were designed to replace the entire open read-
ing frame (ORF) of a given gene with a knock-in cassette that contains a 3XP3-Red Fluorescent Protein (RFP) 
transgene (Supplemental Fig. 1). Thus, the mutation can be followed based on RFP expression in the eye. Null 
alleles were confirmed using Southern blot analyses (Supplemental Fig. 1). In a single case, the KDM3KO allele, a 
portion of the ORF remained in an exogenous location within the targeting vector. Despite the presence of this 
sequence, RT-PCR supported the conclusion that KDM3KO is a null allele (Supplemental Fig. 1). For phenotypic 
confirmation, we also targeted KDM3 using newly developed CRISPR-Cas9 based techniques29, 30, resulting in an 
independent null mutation within the locus (Supplemental Fig. 1). Both of the independently generated knockout 
alleles behaved identically in the assays tested.
To our surprise, the complete knockout collection revealed that out of all 13 JmjC genes, only UTX and Jarid2 
were homozygous lethal17, 19, 24. We rescued the Jarid2KO allele using a genomic-tagged line. Transheterozygotes 
for lid were semi-lethal (below 50% of the expected number of progeny13) while KDM4B mutants were sub-vital 
in males (~64% of the expected number of progeny). The remaining nine knockout mutants were fully viable and 
fertile. To determine whether any of the mutants exhibited developmental timing defects, we allowed control and 
homozygous mutant flies to lay eggs in fresh vials for three hours and monitored when these cohorts progressed 
Figure 1. Conservation and tools generated of Drosophila JmjC genes. The first column (Fly Gene) lists all 
Drosophila JmjC genes, the second (Mammalian Genes) and third (Other Nomenclature) columns are the 
mammalian homologs (with paralogs) with two nomenclatures listed. The fly and mammalian homologs are 
grouped and listed based on their phylogenetic relationship determined by protein domain structure and 
multiple sequence alignments, as presented in (Klose et al., 2006a). The fourth column (Viability in flies) states 
the viability of the fly alleles used in this study. The fifth and sixth columns list the alleles used in this study 
and the transgenic lines generated, respectively. The seventh column (Predicted substrate) states the predicted 
methyl marks targeted by each JmjC protein and the final column illustrates the selected domains for each 
Drosophila protein subclass.
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through pupation and eclosion. All control and mutant flies (n ≥ 30), underwent pupariation and eclosed within 
24 hours of each other.
Previous studies had attributed the lack of phenotypes in individual mouse JmjC mutants to functional 
redundancy between closely related family members31–33. Drosophila encodes for a more limited number of JmjC 
genes, allowing us to directly assay for redundancy within different family subgroups. For example, KDM4A 
and KDM4B belong to the same subgroup, and are predicted to target H3K36me2/3 as well as H3K9me2/334–36 
(Fig. 1). A third JmjC protein, KDM3, can also demethylate H3K9me2/337. We found that the double null mutant 
combination of KDM4AKO and KDM4BKO was semi-lethal, with ~20% of flies surviving to adulthood, consistent 
with a previous study that utilized transposon alleles20. These double mutants could, however, be maintained 
as a homozygous, albeit, weak stock. The two other double mutant combinations, KDM4AKO;KDM3KO and 
KDM4BKO;KDM3KO, were viable and fertile.
We also assayed for redundancy between four members of the JmjC domain-only group, JMJD4, JMJD5, 
JMJD7 and HSPBAP1, based on their common localization to the cytoplasm (Fig. 2 and Supplemental Fig. 2). All 
six double mutant combinations were viable and fertile with no obvious developmental defects. Taken together, 
Figure 2. Subcellular localization of Drosophila JmjC proteins. The top left panel is a sketch of the cassette 
inserted into 3′ end of the JmjC genes to generate a 6xHis-, HA-, C-terminal tag, followed by an RFP-cassette 
flanked by two loxP sites. The RFP-cassette consists of eyeless promoter-driven RFP and Kanamycin. This 
cassette was removed by crossing the lines to a source of Cre, leaving a 34 bp loxP site between the HA tag and 
3′UTR. For all subsequent rows in the figure, the gene is indicated on the side. Salivary glands were stained 
with HA (green; and in greyscale in third and sixth column), counterstained with DAPI for DNA (blue), and 
whole glands and single cells are shown. Scale bar is 20 μm for the entire salivary gland image and 2 μm for the 
single cell image. In three cases (KDM2, PSR and JMJD5) the genomic tag exhibited weak to no expression, 
therefore the UAS-tagged line was used instead, driven by the ubiquitous driver, tubulin (tub)-Gal4. In one line, 
KDM4B::HA, anti-KDM4B was used instead of anti-HA.
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our loss-of-function data and double mutant analyses suggest most JmjC family members do not play an obvious 
role during Drosophila development.
JmjC proteins regulate chromatin structure. We next asked how many JmjC mutants affect chromatin 
organization as predicted by the histone demethylase activity of conserved family members from different spe-
cies38, 39. Drosophila offers a number of well-established assays for evaluating position effect variegation (PEV), 
which quantitatively reports changes in reporter gene expression as a function of neighboring chromatin organ-
ization38, 39 (Fig. 3). The first assay we utilized depends on an inversion, In(1)wm4, that places the white+ gene 
locus, which encodes the gene needed for the formation of red pigment in the Drosophila compound eye, in close 
proximity to pericentric heterochromatin. Expansion of repressive heterochromatin leads to reduced expres-
sion of white+ in a clonally heritable manner resulting in a red-white variegated eye with both pigmented and 
non-pigmented facets (Fig. 3A). Loss of heterochromatin-promoting genes should therefore increase the number 
of pigmented, white+-expressing facets, while loss of genes that promote transcriptionally active euchromatin 
should enhance variegation, leading to fewer white+-expressing facets (Fig. 3A). Eight out of the 13 Drosophila 
JmjC mutant alleles modified In(1)wm4 variegation: KDM3KO, lid10424 40, UTX1 and PSRFM1 enhanced variegation, 
while KDM4AKO, KDM4BKO, NO66KO and JMJD4KO suppressed it (Fig. 3B).
The second assay we tested utilizes the same principle with a different gene as a read-out: a gain-of-function 
allele of Stubble (Sb), that results in short thick bristles, is juxtaposed near heterochromatin and exhibits varie-
gation so that resultant flies carry both short thick Sb bristles and long thin wild-type bristles41 (Fig. 3C). This 
allele is referred to as SbV and in SbV/ + control flies, a mean of 15.6 (+/−3.9) bristles displayed the Sb phenotype, 
while the remaining bristles appeared phenotypically normal (Table 1). Importantly, as in the In(1)wm4assay, lid 
and KDM3KO enhanced the variegation of the SbV allele, while KDM4AKO, KDM4BKO and NO66KO suppressed 
it (Fig. 3D and Table 1). Hence, the chromatin alterations in the JmjC mutants were largely independent of the 
genes used as a read-out in these assays (Fig. 3E), strongly suggesting they play a role in regulating chromatin 
organization.
Figure 3. JmjC mutants modify position-effect variegation. (A) Schematic describing wm4 PEV. (B) Adult fly 
eyes of the indicated genotypes. wm4/Y exhibits variegation of red and white facets and was used as a control 
for all the experiments except for NO66 because the gene is on the X chromosome, therefore wm4/w was used 
as the control. The genotype of each eye is wm4/Y; JmjCKO/+, and for NO66 it is wm4/w NO66KO. (C) Schematic 
describing SbV PEV. (D) A bar graph showing the average number of stubble bristles counted for 20 flies (~560 
bristles) for each genotype. SbV/+ was used as the control. All other genotypes are JmjCKO/+ in the SbV/+ 
background. ****p < 0.0001. (E) A summary of results from both PEV assays and the subcellular localization of 
the particular JmjC protein.
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We next tested whether loss of JmjC genes affected global levels of methyl marks using Western blot analy-
sis. We assayed eight mutant lines (KDM2, KDM3, KDM4A, KDM4B, PSR, NO66, JMJD5, JMJD4), which are 
homozygous viable and predicted to affect specific methyl marks according to published reports on their mam-
malian counterparts (Fig. 1) and/or our PEV assays (Fig. 3). We analyzed equal amounts of extracted histones 
from whole flies using the following antibodies: H3K27me3, H3K4me2, H3K4me3, H3K9me2, H3K36me2 
(Fig. 4). Our western blot analyses do not reveal any obvious global changes in the marks tested. These data are 
not surprising considering a recent report, which also failed to detect global changes in H3K27me3 levels in UTX 
mutant cells in larval imaginal discs using immunohistochemistry19.
JmjC genes modulate different signaling pathways. Our finding that at least eight JmjC mutants affect 
chromatin organization without obviously impairing development raises questions about the roles of such chro-
matin regulation. Do these mutants affect gene regulation, and if yes, under which conditions? Drosophila allows 
for the quantitative assessment of relevant modulatory effects in both genetically sensitized backgrounds as well 
as controlled isogenic wild-type backgrounds. To first test which JmjC genes modulate different pathways that 
specify cell fate and growth, we placed the JmjCKO alleles into three sensitized genetic backgrounds.
Based on previous observations that specific JmjC proteins influence ribosome biogenesis42–44 and that at 









+/+; +/+; SbV/+ 
(control) 20 15.55 ± 3.87 N/A
KDM2KO/SbV 18 17.67 ± 3.6 no
lid10424/+; SbV/+ 20 9.9 ± 4.27 yes****
lidK06801/+; SbV/+ 20 8.2 ± 3.3 yes****
Jarid2KO/+; SbV/+ 20 12.4 ± 2.62 no
UTXΔ/+; SbV/+ 8 14.3 ± 3.68 no
KDM4AKO/+; SbV/+ 20 21.4 ± 2.95 yes****
KDM4BKO/+; SbV/+ 20 23.55 ± 3.22 yes****
UTX1/+; SbV/+ 17 16.18 ± 5 no
KDM3KO/SbV 19 7.53 ± 3.49 yes****
NO66KO/+; +/+; SbV/+ 10 20.1 ± 3.03 yes*
JMJD5KO/SbV 20 16.75 ± 3.67 no
JMJD7KO/SbV 20 17 ± 4.07 no
HSPBAP1KO/SbV 20 15.85 ± 4.40 no
PSRFM1/SbV 10 15.9 ± 2.23 no
JMJD4KO/+; SbV/+ 20 18.65 ± 2.60 no
Table 1. JmjCKO modifies SbV position effect variegation. a28 bristles were scored per fly. bFor each genotype, 
the mean number of bristles was compared to the control genotype and a statistically significant value was 
determined using Dunnett’s multiple comparisons test.
Figure 4. JmjC mutants do not exhibit global changes in selected histone marks. Immunoblots of histones 
extracted from whole flies of the indicated mutants probed with anti-H3.3 to show similar loading levels and 
five antibodies that may be targeted by at least one mutant. Blots were cropped to show the 15 kDa bands. 
Brightness/Contrast levels were not modified. Full-length blots can be found in the supplementary datasets.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 5240  | DOI:10.1038/s41598-017-05004-w
the extent to which Drosophila JmjC mutations modified phenotypes caused by disruption of Pol I activity. We 
employed the Gal4/UAS system to establish a sensitized background in which the Drosophila Pol I transcription 
factor Taf1B45 was knocked-down in the developing eye (ey > Taf1BRNAi). Decreased levels of Taf1B resulted in a 
rough eye phenotype, and the appearance of a malformation that resembled an antennal-like structure in ~35% 
of progeny (Fig. 5A), similar to phenotypes observed upon knockdown of nucleostemin, another factor needed 
for ribosome biogenesis46. UTX1 and UTXΔ enhanced the ey > Taf1BRNAi phenotype, while NO66KO suppressed it 
(Fig. 5B,C). Overexpression of NO66 had the opposite effect and enhanced the ey > Taf1BRNAi phenotype, both in 
terms of severity and penetrance (Fig. 5B,D). Overexpression of NO66 alone using the same driver did not result 
in a phenotype (Fig. 5E), suggesting the effect that NO66 has upon ribosome biogenesis or function can only be 
observed under sensitized conditions. Co-staining with nucleolar markers revealed that NO66 co-localizes with 
Fibrillarin, an rRNA processing factor, but not Udd, a SL1 complex member that regulates Pol I transcription 
(Fig. 5F–I”). These observations suggest NO66 may regulate an aspect of ribosome biogenesis or function down-
stream of rRNA transcription.
We next assayed a sensitized background with modified signaling in the Hippo pathway, which controls 
organ growth and regeneration, and has been implicated in a number of human cancers47. Overexpression of 
an activated version of Yorkie (UAS-YkiS168A), the transcriptional activator of the Hippo pathway48, in the eye 
results in a striking overgrowth phenotype49 (Fig. 6A), caused by increased transcription of pro-proliferation and 
anti-apoptotic target genes48. We systematically tested all JmjC mutants in this background and found that loss 
of UTX enhanced the ey > YkiS168A phenotype while loss of JMJD5 and NO66 suppressed it (Supplemental Fig. 3 
and Fig. 6B,C).
Figure 5. NO66KO strongly modifies a growth phenotype in the eye. (A,C–E) Adult eyes of the indicated 
genotypes. (A) ey-Gal4 UASt-Taf1B-RNAi/ + displays an eye to antenna transformation in ~35% of progeny. (B) 
A graph representing the number of eye to antenna transfomations in the genotypes ey > Taf1B-RNAi/ + with 
JmjCKO/+, or UASp-NO66. *P < 0.005. (C) NO66KO/+ suppresses the phenotype, and (D) UASp-NO66 enhances 
the phenotype, while (E) overexpression of NO66 alone has no phenotype. (F,G”) Salivary gland cells of the 
genomic tag NO66::HA stained with anti-HA (green, NO66), anti-Fib (red) and DAPI (blue), followed by single 
channels in greyscale. (H,I”) Salivary gland cells of the genomic tag NO66::HA stained with anti-HA (green, 
NO66), anti-Udd (red) and DAPI (blue), followed by single channels in greyscale. Scale bar is 20 μm.
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Thirdly, we assayed a sensitized background with modified hedgehog signaling, which instructs cellular dif-
ferentiation. A previous study suggested a link between histone demethylation and the hedgehog pathway in 
mammals50. We used an established assay, based on overexpression of a dominant-negative form of Smoothened 
(Smo5A) throughout the developing wing, which results in disrupted wing veins that varies from mild to severe 
and is 100% penetrant (Fig. 6F ref. 51). Control flies display 14% severe vein disruption (Supplemental Fig. 4). 
We systematically crossed all the JmjC mutations into this background and counted the number of progeny that 
displayed a mild or severe wing vein phenotype. KDM4AKO (60%) and KDM4BKO (49%) displayed a significantly 
higher percentage of severe wing vein disruption (Fig. 6G,H and Supplemental Fig. 4), while PSRFM1 showed a 
tendency towards enhancement (25%) and KDM3KO progeny exhibited only the mild phenotype. The other JmjC 
mutations did not modify the phenotype in a significant way (Supplemental Fig. 4).
Taken together, our data show that different JmjC mutants modulate each of the three sensitized background 
we assayed. Four of the eight mutants that tested positive for chromatin regulation, but had no overall devel-
opmental defects, cause strong alterations in these three assays. These findings show that different JmjC muta-
tions have different and specific modulatory effects depending on the genetic perturbation causing the primary 
phenotype.
Discussion
Here, we report the systematic functional characterization of the Drosophila JmjC gene family, which includes 
many known histone demethylases. We achieved this by creating a genetic toolkit that contains tagged transgenic 
lines and loss-of-function mutations for all 13 annotated Drosophila JmjC domain genes. To our knowledge, 
this study represents the first systematic characterization of this entire gene family in a multicellular organism. 
JmjC domain histone demethylases have been implicated in the development of multicellular organisms and in a 
number of human diseases, including cancer52–54. While null alleles of several JmjC domain genes result in devel-
opmental defects and embryonic death in mice, others do not. The lack of developmental phenotypes in these 
mutants has been attributed to functional redundancy between closely related family members within the same 
subgroup. Unexpectedly, our genetic characterization of null or strong loss-of-function alleles reveals that only 
Figure 6. Specific JmjC mutant alleles modify phenotypes caused by disruption of two different signaling 
pathways. (A–C) Adult eyes of the indicated genotypes. Disruption of the Hippo pathway by overexpressing 
constitutively active YkiS168A, using the eye driver GMR-Gal4, results in a massively overgrown eye (A). 
Removing one copy of UTXΔ (B) enhances, and removing one copy of JMJD5KO (C) suppresses this phenotype. 
(D–H) Adult wings of the indicated genotypes. Disruption of the Hedgehog pathway by overexpressing Smo5A, 
using the wing driver C765-Gal4, results in wing vein phenotypes (arrowheads) (E). Removing one copy of 
either KDM4AKO (F) and KDM4BKO (G) or PSRFM1 (H) enhances the phenotype.
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mutations in two JmjC genes, UTX and Jarid2, exhibit lethality in Drosophila, while a third mutant, lid, displays 
semi-lethality13, 17, 55. The remaining ten are homozygous viable and fertile, with no readily obvious phenotypes. 
In addition, our double mutant analyses reveal genetic redundancy between KDM4A and KDM4B, consistent 
with another study20, but no other JmjC family members. While these data do not preclude the possibility that 
the requirements of individual JmjC proteins during mammalian development are obscured by the function of 
closely related subgroup members, our analyses suggest an alternative possibility: that JmjC domain proteins 
more generally modulate and fine-tune gene expression programs in ways that only become obvious in sensi-
tized genetic backgrounds. Parallel findings that JmjC mutations disruption normal sleep, activity and circadian 
rhythm patterns bolster the conclusion that JmjC proteins modulate varied functional outputs (Shalaby, Pinzon et 
al. 2017). Thus, our data suggest that despite the absence of severe developmental defects, this gene family is still 
broadly important for numerous physiological processes. Such functions are, most likely, essential for survival 
outside of a laboratory setting.
A number of JmjC genes have been shown to encode histone demethylases and to affect transcription/chroma-
tin4. Consistent with this model, eight out of the 13 JmjC gene mutants affected chromatin organization based on 
two different PEV assays. Of these modifiers, KDM3KO, lid10424, UTXΔ and PSRFM1 enhanced variegation, suggest-
ing these genes promote gene expression. By contrast, KDM4AKO, KDM4BKO, JMJD4KO and NO66KO suppressed 
variegation, indicating that these genes likely participate in gene silencing and heterochromatin formation. These 
findings are consistent with known histone demethylation activities across species of; KDM3, UTX, KDM4A and 
KDM4B, NO664, 5, 56, 57 and expand the list further to include more members, namely PSR and JMJD4.
Novel functions for JmjC genes. Mutations in KDM2, JMJD5, JMJD7 and HSPBAP1 do not modify varie-
gation of either the wm4 or SbV phenotypes, suggesting these proteins may target non-histone substrates or carry 
out other biochemical functions58. Consistent with this hypothesis, recent studies have indicated that JMJD5, 
JMJD7 as well as NO66 likely function as hydroxylases, and not as histone demethylases as previously thought44, 
59. Interestingly, NO66 localizes to the nucleolus and has been shown to hydroxylate ribosomal proteins44, 59. 
Determining the molecular mechanisms by which these proteins act as modulators, and whether this depends on 
chromatin-based mechanisms, remains important work for the future.
The loss of specific JmjC domain proteins also impacts different signaling pathways. Similar to the modifica-
tion of reduced Pol I activity, this modulation only becomes apparent in perturbed, or sensitized genetic back-
grounds. Mutations in different JmjC domain genes modify Hippo and Hedgehog pathway phenotypes in the 
eye and wing respectively. Thus, our results indicate that several JmjC genes modulate critical signaling pathways 
required for normal growth and development. In multicellular organisms, JmjC proteins may buffer what would 
otherwise be large changes in signaling pathway activity and gene expression in certain contexts. These obser-
vations are interesting in light of previous results implicating a number of JmjC proteins in cancer. For exam-
ple, UTX mutations have been linked with multiple tumor types including myeloma, squamous cell carcinoma 
and leukemia60–64. Taken together with our findings of enhancement of the Hippo pathway phenotype by UTX, 
these observations suggest that UTX negatively regulates growth in numerous contexts. Conversely, the striking 
suppression of the eye outgrowth phenotype by JMJD5KO suggests that this protein may be an effective target 
for controlling Hippo pathway-dependent growth. Given its cytoplasmic localization and its inability to modify 
either of the two PEV assays tested, we propose JMJD5 likely targets non-histone substrates. Disruption of normal 
hedgehog signaling has also been linked with various forms of cancer, including medulloblastoma and basal cell 
carcinoma65. The results reported here show that KDM4A, KDM4B and PSR interact with the hedgehog pathway 
in a functionally significant manner. Further characterization of the genetic and molecular relationships between 
different JmjC proteins and various signaling pathways in model systems will help identify which family members 
represent potential therapeutic targets for the treatment of human disease.
Together, the data presented here show that many Drosophila JmjC proteins modulate changes in chroma-
tin organization and gene expression programs. Contrary to expectations, however, most JmjC genes are not 
required for viability, but are modulators of chromatin organization and critical signaling pathways. These find-
ings contribute to our understanding of some phenotypes observed in cultured cells, many of which are highly 
genetically altered and sensitized. They also further open the door to experimental and therapeutic exploration of 
how critical signaling pathways are kept in check, or dysregulated in numerous disease conditions in both model 
organisms and humans.
Methods
Fly Stocks. The following lines were acquired from the Bloomington Stock Center: w1118 (BL# 38690), hsFlp,h-
sIscel/CyO (BL # 6934), nanos-Gal4 (BL# 32179), Tubulin-Gal4 (BL# 5138), eyeless-Gal4 (BL# 8227), In(1)whitem4 
(BL# 807), Sb[V] (BL# 878), Cre (BL# 1501) lid10424 (BL# 12367), lidk06801 (BL# 10403). PSRFM1 was provided by 
Kristin White (Massachusetts General Hospital, Charlestown, MA), FRT40A, UTX1 was provided by Andreas 
Bergmann (M. D. Anderson Cancer Center, Houston, TX), FRT40A, UTXΔ was provided by Jürg Müller (MPI of 
Biochemistry, Chromatin and Chromosome Biology, Martinsried, Germany).
Generating His-HA tagged and knockin cassettes. All primers used for this study are listed in 
Supplemental Materials and Methods. Both His-HA tagged genomic cassettes and knockin cassettes were gen-
erated using a combination of in vivo bacterial recombineering and GatewayTM Technology (Chan et al., 2011; 
Chan et al., 2012; Carreira-Rosario et al., 2013). Briefly, 500 bp homology arms were amplified approximately 
10 kb upstream and 10 kb downstream of the ORF in 6/10 knockouts generated; CG3654, CG13902, CG12879, 
CG7200, CG8165, CG10133, or asymmetric homology arms in 4/10 knockouts generated; CG33182, CG11033, 
CG2982 and CG15835 (see Supplemental Fig. 1). The homology arms were amplified using “left arm” and “right 
arm” primer pairs using PCR Soe with a BamHI site in the middle and the GatewayTM attB sequence at the ends. 
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The resulting 1 kb PCR product was cloned into a P[acman] vector using BP clonase (Life technologies), which 
we had re-engineered to include the GatewayTM attP site, and FRT and I-Sce I sites necessary for ends-out homol-
ogous recombination (Gong and Golic, 2003; Chan et al., 2011; Carreira-Rosario et al., 2013). The vector was 
then transformed into EPI300 electrocompetent cells (Epicentre), and DNA was prepared from a single colony, 
digested using BamHI and used for the “first round” of recombineering with the appropriate Bacterial Artificial 
Chromosome (BAC) for each gene. This resulted in a P[acman] vector containing approximately 13–20 kb 
genomic DNA flanking the ORF of interest. To replace the ORF with our knockin cassette we used PCR Soe to 
amplify 50 bp homology arms flanking each ORF along with the knockin cassette which consisted of: loxP-3X 
PAX3 promoter, RFP ORF, RFP 3′UTR, Kanamycin, Kanamycin 3′UTR and a loxP at the end. A “second round” 
of recombineering was performed using the knockout cassette and the P[acman] vector containing genomic 
DNA. Finally, the P[acman] vectors containing the genomic DNA with the ORF replaced by the knockin cassette 
were validated by sequencing across the cassette, and then sent to Rainbow Transgenics for injection into a pre-
determined landing site using PhiC31 intergrase (BL# 24871). To generate the tagged lines, the “second round” 
of recombineering was performed using a PCR Soe product that contained 50 bp homology arms upstream and 
downstream the stop codon of each ORF. The tag cassette consisted of: loxP-His-HA-3X PAX3 promoter, RFP 
ORF, RFP 3′UTR, Kanamycin, Kanamycin 3′UTR and a loxP at the end.
Generating knockouts using ends-out homologous recombination. Given the large size of the vec-
tors (~25–30 kb), around 300–600 embryos were injected to ensure we would obtain at least one transgenic line. 
Flies containing integrated transformants were identified by the expression of mini-white and RFP in the adult 
eyes. Transgenic lines were then crossed to flies carrying hs-Flp, hs-I-Scel (BL # 6934). First and second instar 
larvae were subjected to 37 °C heatshock treatments for 2 hrs, three times a day, for five consecutive days. The 
resulting female virgin progeny were crossed to y w males; 3 females and 3 males in each cross, and around 200 
crosses were set for each gene. From these crosses, we screened approximately 6000 flies for mobilization events, 
which were isolated based on the expression of RFP in the eye, and absence of white and yellow. These “potential 
knockouts” were balanced and a Southern blot was performed to confirm the incidence of a knockout.
Generating KDM3KO-2 using Crispr/Cas9. To generate the CRIPSR/Cas9 KDM3KO-2 allele, guide RNAs 
were designed using http://tools.flycrispr.molbio.wisc.edu/targetFinder and synthesized as 5′-unphosphorylated 
oligonucleotides, annealed, phosphorylated and ligated into the BbsI sites of pU6-BbsI-chiRNA plasmid (Gratz 
et al., 2013). Homology arms were synthesized as gene blocks (IDT) and cloned into pHD-dsRed-attP (Gratz 
et al., 2014) (Addgene). Guide RNAs and the donor vector were co-injected into nosP Cas9 attP embryos at the 
following concentrations: 250 ng/µl pHD-dsRed-attP donor vector and 20 ng/µl of each of the pU6-BbsI-chiRNA 
plasmids containing the guide RNAs (Rainbow Transgenics Inc.).
Southern blotting. Genomic DNA was isolated from 30 flies as previously described (http://www.fruitfly.
org:9005/about/methods/inverse.pcr.html). 10 μg of genomic DNA was digested overnight in final volume of 
50 μl. The resulting digest was run on a 0.4–0.7% agarose gel overnight at 4 °C at 35 V. The gel was incubated in 
Denaturing solution (1.5 M NaCl, 0.5 M NaOH in water) for 45 min, followed by Depurinating solution (0.2 N 
HCl) for 15 min, rinsed several times in distilled water, then incubated in Neutralizing solution (1 M Tris, pH 
7.4, 1.5 M NaCl, ~70 ml 37% HCl) for 30 min. The DNA was transferred to nitrocellulose and crosslinked using 
standard protocols. Hybridization buffer (Roche, DIG Easy Hyb Granules # 11 796 895 001) was prepared and 
incubated for 30 min at 42 °C. Membrane was incubated in pre-heated hybridization buffer for 30 min at 42 °C. 
DIG-labeled probe was added to pre-heated hybridization buffer (5 μl probe in 10 ml buffer) and incubated in a 
rotating oven overnight at 42 °C. The membrane was washed twice (20 min each wash) in 2X SSC; 0.1% SDS at 
room temperature (RT), then washed twice (30 min each wash) in 0.5X SSC; 0.1% SDS at 68 °C, agitating con-
stantly, rinsed in maleic acid buffer for 5 min with shaking at RT, blocked in 1% blocking buffer (Roche# 11 096 
176 001) in maleic acid 1–3 hrs at RT. Anti-DIG antibody (Roche# 11 093 274 910) was diluted 1:10,000 in fresh 
blocking buffer and incubated with membrane for 30 min at RT with gentle shaking. Membrane was then washed 
for 2X 15 min in wash buffer (30 ml Maleic acid buffer, 90 μl Tween 20), rinsed in detection buffer (100 mL 1 M 
Tris pH 9.5, 20 ml 5 M NaCl) for 5 min. Membrane was incubated with CDP-Star solution (Applied Biosystems 
T2146) and exposed to film for 5–20 min.
Overexpression constructs. cDNA clones were amplified from the appropriate DGC vector or from 
genomic DNA, and cloned into pENTR™/D-TOPO® vector (Life Technologies). The Gateway destination vector 
pPHW was modified to include an attB site to be used for PhiC31 integration into a predetermined landing site 
in the genome. See Supplemental Methods for a list of DGC clones, primers and landing sites used for each gene.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Total RNA was isolated from whole 
flies using TRIzol extraction (Invitrogen). The RT reaction was performed using SuperScript® III First-Strand 
Synthesis SuperMix (Invitrogen) with random hexamers, followed by regular PCR using gene-specific primers 
(see Supplemental Methods for primer sequences).
Immunohistochemistry, microscopy and image processing. Third instar larvae were dissected in 
1XPBS and the salivary glands were isolated, fixed for 10 min in 4% formaldehyde, washed 3X, 10 min each, in 
PBT (1X PBS, 0.3% Triton-X-100, 0.5% BSA), and incubated in primary antibody diluted in PBT overnight at 
4 °C. Next day, samples were washed 3X, 10 min each, in PBT and incubated in secondary antibodies diluted in 
PBT at RT for 4 hrs in the dark. Samples were then washed twice in PBT and once in 1X PBS. Salivary glands were 
mounted on a slide with a drop of Vectashield mounting medium with DAPI (Vector Laboratories, Inc.). For 
ovaries, adult females were fattened for 2 days on media containing wet yeast and dissected and stained as above. 
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 5240  | DOI:10.1038/s41598-017-05004-w
The antibodies rat anti-HA 3F10 (Roche, 1:100), mouse anti-Fibrillarin 38F3 (1:800), guinea pig anti-Udd (1:800), 
Fluorescence-conjugated secondary antibodies; Cy3, Cy5, FITC (Jackson Laboratories) and Alexa488 (Molecular 
Probes) were used at 1:200. Images were taken using Leica SP5, processed in Image J Software and compiled in 
Photoshop CS4.
Generation of KDM4B antibody. Sequence corresponding to the last 187 residues of KDM4B was cloned 
into PROEX (Invitrogen). Recombinant protein was purified from E.coli using Ni2+ resin (Qiagen). The purified 
protein was used to generate polyclonal guinea pig antisera (Covance).
Histone extraction and western blot analyses. Histone proteins were extracted from whole flies fol-
lowing the acid-histone extraction procedure described in Shechter et al.66 with the following modifications: ~1 ml 
of adult flies were pulverized using liquid nitrogen and incubated in 500 µl hypotonic lysis buffer [10 mM Tris-Cl, 
1 mM KCl, 1.5 mM MgCl, 1 mM DTT and a protease inhibitor tablet (cOmplete™, Mini Protease Inhibitor 
Cocktail, Roche #11836153001] and 0.4 N H2SO4 acid for 30 min at 4 °C. Samples were spun in a cooled centri-
fuge at 16,000 g for 10 min and the supernatant was transferred to a fresh 1.5 ml tube. Trichloroacetic acid (TCA) 
was added to the supernatant to a final concentration of 10% and incubated for 10 min at 4 °C. Histones were pel-
leted by centrifugation in a cooled centrifuge at 2,000 g for 10 min. Pellets were washed in 1 ml ice-cold Acetone 
several times, then carefully aspirated and the pellet was left to dry on ice for 5 min and finally resuspended in 
100 µl ice-cold water. The following primary antibodies were used for western blot analysis at 1:1000: anti-H3.3 
(Millipore), anti-H3K27me3 (Millipore), anti-H3K4me2 (Abcam), anti-H3K4me3 (Millipore), anti-H3K9me2 
(Millipore), anti-H3K36me2 (Millipore) and the secondary antibody goat anti-rabbit-HRP (Bio-Rad, 1:5000).
Phenotypic assessment of adults. Adult eye pictures were taken by collecting adult flies and placing 
them at −20 °C for one hour, then gluing them onto a slide. Adult wings were mounted in mineral oil. Pictures of 
eyes and wings were taken using the Leica MZ16 In-Focus system and all images were assembled in Photoshop 
CS4. For the SbV assay, 28 bristles were counted on ~20 adult flies, including the sternopleural, humeral and 
macrochaete bristles. Statistical analyses for all assays were performed using either the one-way ANOVA test, 
Dunnett’s multiple comparisons, Fisher exact test, with Bonferroni correction or the t-test with two-tailed distri-
bution with unequal variance in Graphpad Prism.
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